The American Society for Metabolic and Bariatric Surgery says its most-recent data shows surgeons performed nearly 300,000 ...

Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.

Gain insight on Centessa Pharmaceuticals, Novo Nordisk and more in the latest Market Talks covering the Health Care sector.

Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...

WSHU sits down with CT Mirror’s Katy Golvala to discuss her story about the debate over Medicaid coverage of weight loss ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

Comedian Amy Schumer opened up about the weight-loss drug that's helped give her more energy after making a big switch ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company the United Bio-Technology (Hengqin) Co., as it looks to ...

GLP-1 weight loss drugs cost CT’s Medicaid program $85 million in FY 2024, 35% of annual Medicaid pharmaceutical budget ...